Key result
Nucleotide receptors, particularly P2Y1, P2Y13, and P2X7, regulate the balance between cell survival and apoptosis via intracellular pathways to protect against neurodegeneration and brain injury.
Why the study?
Unraveling the roles and intracellular signaling cascades of nucleotide P2 receptors across cellular contexts may help delineate future therapeutic applications for neuroprotection.
Nucleotide receptors (P2Y1, P2Y13, P2X7) play a crucial role in regulating the balance between cell survival and apoptosis in neurodegeneration models.
Answers are grounded in this paper and cite their sources.
May inform neuroprotective strategies; leaves open clinical translation of P2 receptor modulation.
Nucleotides can contribute to the survival of different glial and neuronal models at the nervous system via activation of purinergic P2X and P2Y receptors. Their activation counteracts different proapoptotic events, such as excitotoxicity, mitochondrial impairment, oxidative stress and DNA damage, which concur to elicit cell loss in different processes of neurodegeneration and brain injury. Thus, it is frequent to find that different neuroprotective mediators converge in the activation of the same intracellular survival pathways to protect cells from death. The present review focuses on the role of P2Y 1 and P2Y 13 metabotropic receptors, and P2X7 ionotropic receptors to regulate the balance between survival and apoptosis. In particular, we analyze the intracellular pathways involved in the signaling of these nucleotide receptors to elicit survival, including calcium/PLC, PI3K/Akt/GSK3, MAPK cascades, and the expression of antioxidant and antiapoptotic genes. This review emphasizes the novel contribution of nucleotide receptors to maintain cell homeostasis through the regulation of MAP kinases and phosphatases. Unraveling the different roles found for nucleotide receptors in different models and cellular contexts may be crucial to delineate future therapeutic applications based on targeting nucleotide receptors for neuroprotection.
No takes yet. Share an insight, caveat, or question.
Miras‐Portugal et al. (2018) conducted a review in Neurodegeneration and brain injury. Nucleotide receptors (P2Y1, P2Y13, P2X7) was evaluated. Nucleotide receptors, particularly P2Y1, P2Y13, and P2X7, regulate the balance between cell survival and apoptosis via intracellular pathways to protect against neurodegeneration and brain injury.
Synapse has enriched 10 related papers. Consider them for comparative context: